This Intracranial Stents market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
The intracranial stents market size has grown rapidly in recent years. It will grow from $0.48 billion in 2024 to $0.55 billion in 2025 at a compound annual growth rate (CAGR) of 15%. The growth in the historic period can be attributed to increased awareness of stroke risks, improved patient education, rise in radiation safety measures, increased aging population, emergence of minimally invasive techniques.
The intracranial stents market size is expected to see rapid growth in the next few years. It will grow to $1 billion in 2029 at a compound annual growth rate (CAGR) of 16.3%. The growth in the forecast period can be attributed to expansion of telehealth services, adoption of genomic medicine, rising healthcare infrastructure, expansion of stroke rehabilitation services, rising health initiatives. Major trends in the forecast period include adoption of bioresorbable intracranial stents, adoption of neurointerventional robotics, integration of advanced imaging technologies, adoption of pediatric intracranial stents, developing dual antiplatelet therapy strategies.
The anticipated rise in the incidence of brain aneurysms is poised to drive the growth of the intracranial stents market in the coming years. Characterized by the development of a bulge in the blood vessels of the brain, a brain aneurysm poses the risk of rupture, leading to brain hemorrhage and potential fatality. Intracranial vessel stenting (IVS) emerges as a minimally invasive treatment for addressing serious cerebral artery stenosis, a condition involving the weakening of arteries delivering blood to the brain. Reports indicate that approximately 3.2% of individuals worldwide have unruptured aneurysms, underscoring the significance of the increasing incidence of brain aneurysms in driving the growth of the intracranial stents market.
The surge in medical imaging tests is expected to propel the growth of the intracranial stents market. Medical imaging tests, also known as diagnostic imaging tests, constitute a set of techniques employed by healthcare professionals to create visual representations of the interior of the human body. Intracranial stents play a crucial role in endovascular treatment for cerebrovascular conditions, providing structural support, enhancing blood flow, and preventing complications. Medical imaging tests are instrumental in diagnosing, guiding, and assessing these procedures, ensuring the accurate and effective placement of intracranial stents. With 43.3 million imaging tests recorded in England between April 2021 and March 2022, the increasing reliance on medical imaging tests contributes significantly to the growth of the intracranial stents market.
Major companies in the intracranial stents market are actively innovating, exemplified by the introduction of new products like the Onyx Frontier drug-eluting stent (DES) by Medtronic plc. Launched in August 2022, the Onyx Frontier DES is designed to treat coronary artery disease (CAD) caused by plaque accumulation in coronary arteries. Its architecture makes it suitable for sophisticated percutaneous cardiac intervention (PCI) with superior deliverability. Another notable innovation is the Pegasus HPC stent system, introduced by Wallaby Medical LLC in September 2022. This medical device is utilized for endovascular repair of the neck and intracranial arteries in patients with intracranial aneurysms and stenoses in intracranial atherosclerotic disease (ICAD).
Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), an autonomous institute under the Department of Science & Technology (DST) of the Government of India and part of the Technical Research Centre (TRC), has announced that it has entered into Technology Transfer Agreements with Biorad Medisys. These agreements involve two biomedical implant devices: an Atrial Septal Defect Occluder and Intracranial Flow Diverter Stents, which were developed by the institute in collaboration with the National Aerospace Laboratories, Bangalore (CSIR-NAL), using superelastic NiTiNOL alloys. Biorad Medisys is an India-based company that specializes in the manufacture of various implants and surgical devices.
Major companies operating in the intracranial stents market include Medtronic plc, Balt Extrusion LLC., Stryker Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, Acandis GmbH, Admedes Schuessler GmbH, MicroVention Inc., Phenox GmbH, Terumo Corporation, Johnson & Johnson Services Inc., Abbott Laboratories, Brainlab AG, Cardiatis SA, Cook Medical LLC, DePuy Synthes, Endologix Inc., InspireMD Inc., Integra LifeSciences Corporation, Kaneka Corporation, Kerecis Limited, Penumbra Inc., Rapid Medical Ltd., Vascular Solutions Inc., W. L. Gore & Associates Inc., Biotronik SE & Co. KG, Cardionovum GmbH, Codman Neuro, C.R. Bard Inc., Cerebral Stents.
North America was the largest region in the intracranial stents market in 2024. Asia-Pacific is expected to be the fastest region in the intracranial stents market share during the forecast period. The regions covered in the intracranial stents market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the intracranial stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
The intracranial stents market consists of sales of Neuroform stents, Solitaire, Enterprise, and Leo plus, and Wingspan stent. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Intracranial stents are tubular devices placed inside blood vessels, canals, or ducts, primarily used for treating intracranial stenosis and brain aneurysms by opening blocked arteries.
The primary types of intracranial stents include self-expanding stents, balloon-expanding stents, and stent-assisted coil embolization. Self-expanding stents expand autonomously after insertion into the intended lumen, such as a blood vessel or organ. Balloon-expanding stents, also known as balloon-expandable stents, offer higher radial stiffness and more precise placement, designed to address restenosis in the iliac artery by opening clogged arteries and restoring blood flow. Stent-assisted coil embolization plays a role in stabilizing coils within an aneurysm, providing support for coil deposition while preventing coil herniation into the parent vessel lumen. These intracranial stents are applied in the treatment of conditions such as brain aneurysms and intracranial stenosis, and find utilization in various sectors including hospitals, ambulatory surgery centers, and others.
The intracranial stents market research report is one of a series of new reports that provides intracranial stents market statistics, including intracranial stents industry, intracranial stents global market size, regional shares, competitors with intracranial stents market share, detailed intracranial stents market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial stents industry. This intracranial stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The intracranial stents market size has grown rapidly in recent years. It will grow from $0.48 billion in 2024 to $0.55 billion in 2025 at a compound annual growth rate (CAGR) of 15%. The growth in the historic period can be attributed to increased awareness of stroke risks, improved patient education, rise in radiation safety measures, increased aging population, emergence of minimally invasive techniques.
The intracranial stents market size is expected to see rapid growth in the next few years. It will grow to $1 billion in 2029 at a compound annual growth rate (CAGR) of 16.3%. The growth in the forecast period can be attributed to expansion of telehealth services, adoption of genomic medicine, rising healthcare infrastructure, expansion of stroke rehabilitation services, rising health initiatives. Major trends in the forecast period include adoption of bioresorbable intracranial stents, adoption of neurointerventional robotics, integration of advanced imaging technologies, adoption of pediatric intracranial stents, developing dual antiplatelet therapy strategies.
The anticipated rise in the incidence of brain aneurysms is poised to drive the growth of the intracranial stents market in the coming years. Characterized by the development of a bulge in the blood vessels of the brain, a brain aneurysm poses the risk of rupture, leading to brain hemorrhage and potential fatality. Intracranial vessel stenting (IVS) emerges as a minimally invasive treatment for addressing serious cerebral artery stenosis, a condition involving the weakening of arteries delivering blood to the brain. Reports indicate that approximately 3.2% of individuals worldwide have unruptured aneurysms, underscoring the significance of the increasing incidence of brain aneurysms in driving the growth of the intracranial stents market.
The surge in medical imaging tests is expected to propel the growth of the intracranial stents market. Medical imaging tests, also known as diagnostic imaging tests, constitute a set of techniques employed by healthcare professionals to create visual representations of the interior of the human body. Intracranial stents play a crucial role in endovascular treatment for cerebrovascular conditions, providing structural support, enhancing blood flow, and preventing complications. Medical imaging tests are instrumental in diagnosing, guiding, and assessing these procedures, ensuring the accurate and effective placement of intracranial stents. With 43.3 million imaging tests recorded in England between April 2021 and March 2022, the increasing reliance on medical imaging tests contributes significantly to the growth of the intracranial stents market.
Major companies in the intracranial stents market are actively innovating, exemplified by the introduction of new products like the Onyx Frontier drug-eluting stent (DES) by Medtronic plc. Launched in August 2022, the Onyx Frontier DES is designed to treat coronary artery disease (CAD) caused by plaque accumulation in coronary arteries. Its architecture makes it suitable for sophisticated percutaneous cardiac intervention (PCI) with superior deliverability. Another notable innovation is the Pegasus HPC stent system, introduced by Wallaby Medical LLC in September 2022. This medical device is utilized for endovascular repair of the neck and intracranial arteries in patients with intracranial aneurysms and stenoses in intracranial atherosclerotic disease (ICAD).
Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), an autonomous institute under the Department of Science & Technology (DST) of the Government of India and part of the Technical Research Centre (TRC), has announced that it has entered into Technology Transfer Agreements with Biorad Medisys. These agreements involve two biomedical implant devices: an Atrial Septal Defect Occluder and Intracranial Flow Diverter Stents, which were developed by the institute in collaboration with the National Aerospace Laboratories, Bangalore (CSIR-NAL), using superelastic NiTiNOL alloys. Biorad Medisys is an India-based company that specializes in the manufacture of various implants and surgical devices.
Major companies operating in the intracranial stents market include Medtronic plc, Balt Extrusion LLC., Stryker Corporation, MicroPort Scientific Corporation, Boston Scientific Corporation, Acandis GmbH, Admedes Schuessler GmbH, MicroVention Inc., Phenox GmbH, Terumo Corporation, Johnson & Johnson Services Inc., Abbott Laboratories, Brainlab AG, Cardiatis SA, Cook Medical LLC, DePuy Synthes, Endologix Inc., InspireMD Inc., Integra LifeSciences Corporation, Kaneka Corporation, Kerecis Limited, Penumbra Inc., Rapid Medical Ltd., Vascular Solutions Inc., W. L. Gore & Associates Inc., Biotronik SE & Co. KG, Cardionovum GmbH, Codman Neuro, C.R. Bard Inc., Cerebral Stents.
North America was the largest region in the intracranial stents market in 2024. Asia-Pacific is expected to be the fastest region in the intracranial stents market share during the forecast period. The regions covered in the intracranial stents market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the intracranial stents market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.
The intracranial stents market consists of sales of Neuroform stents, Solitaire, Enterprise, and Leo plus, and Wingspan stent. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
Intracranial stents are tubular devices placed inside blood vessels, canals, or ducts, primarily used for treating intracranial stenosis and brain aneurysms by opening blocked arteries.
The primary types of intracranial stents include self-expanding stents, balloon-expanding stents, and stent-assisted coil embolization. Self-expanding stents expand autonomously after insertion into the intended lumen, such as a blood vessel or organ. Balloon-expanding stents, also known as balloon-expandable stents, offer higher radial stiffness and more precise placement, designed to address restenosis in the iliac artery by opening clogged arteries and restoring blood flow. Stent-assisted coil embolization plays a role in stabilizing coils within an aneurysm, providing support for coil deposition while preventing coil herniation into the parent vessel lumen. These intracranial stents are applied in the treatment of conditions such as brain aneurysms and intracranial stenosis, and find utilization in various sectors including hospitals, ambulatory surgery centers, and others.
The intracranial stents market research report is one of a series of new reports that provides intracranial stents market statistics, including intracranial stents industry, intracranial stents global market size, regional shares, competitors with intracranial stents market share, detailed intracranial stents market segments, market trends and opportunities, and any further data you may need to thrive in the intracranial stents industry. This intracranial stent market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Intracranial Stents Market Characteristics3. Intracranial Stents Market Trends and Strategies4. Intracranial Stents Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Intracranial Stents Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Intracranial Stents Market34. Recent Developments in the Intracranial Stents Market
5. Global Intracranial Stents Growth Analysis and Strategic Analysis Framework
6. Intracranial Stents Market Segmentation
7. Intracranial Stents Market Regional and Country Analysis
8. Asia-Pacific Intracranial Stents Market
9. China Intracranial Stents Market
10. India Intracranial Stents Market
11. Japan Intracranial Stents Market
12. Australia Intracranial Stents Market
13. Indonesia Intracranial Stents Market
14. South Korea Intracranial Stents Market
15. Western Europe Intracranial Stents Market
16. UK Intracranial Stents Market
17. Germany Intracranial Stents Market
18. France Intracranial Stents Market
19. Italy Intracranial Stents Market
20. Spain Intracranial Stents Market
21. Eastern Europe Intracranial Stents Market
22. Russia Intracranial Stents Market
23. North America Intracranial Stents Market
24. USA Intracranial Stents Market
25. Canada Intracranial Stents Market
26. South America Intracranial Stents Market
27. Brazil Intracranial Stents Market
28. Middle East Intracranial Stents Market
29. Africa Intracranial Stents Market
30. Intracranial Stents Market Competitive Landscape and Company Profiles
31. Intracranial Stents Market Other Major and Innovative Companies
35. Intracranial Stents Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Intracranial Stents Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on intracranial stents market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for intracranial stents? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The intracranial stents market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) Covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Self Expanding Stents; Balloon Expanding Stents; Stent-Assisted Coil Embolization2) By Disease Indication: Brain Aneurysm; Intracranial Stenosis
3) By End-User: Hospitals; Ambulatory Surgery Centers; Other End-Users
Subsegments:
1) By Self-Expanding Stents: Neurovascular Self-Expanding Stents; Biodegradable Self-Expanding Stents2) By Balloon Expanding Stents: Drug-Eluting Balloon Expanding Stents; Bare Metal Balloon Expanding Stents
3) By Stent-Assisted Coil Embolization: Detachable Coil Systems; Non-Detachable Coil Systems
Key Companies Mentioned: Medtronic plc; Balt Extrusion LLC.; Stryker Corporation; MicroPort Scientific Corporation; Boston Scientific Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Intracranial Stents market report include:- Medtronic plc
- Balt Extrusion LLC.
- Stryker Corporation
- MicroPort Scientific Corporation
- Boston Scientific Corporation
- Acandis GmbH
- Admedes Schuessler GmbH
- MicroVention Inc.
- Phenox GmbH
- Terumo Corporation
- Johnson & Johnson Services Inc.
- Abbott Laboratories
- Brainlab AG
- Cardiatis SA
- Cook Medical LLC
- DePuy Synthes
- Endologix Inc.
- InspireMD Inc.
- Integra LifeSciences Corporation
- Kaneka Corporation
- Kerecis Limited
- Penumbra Inc.
- Rapid Medical Ltd.
- Vascular Solutions Inc.
- W. L. Gore & Associates Inc.
- Biotronik SE & Co. KG
- Cardionovum GmbH
- Codman Neuro
- C.R. Bard Inc.
- Cerebral Stents.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 0.55 Billion |
| Forecasted Market Value ( USD | $ 1 Billion |
| Compound Annual Growth Rate | 16.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
